Literature DB >> 17661044

[Bronchoalveolar lavage].

M Tötsch1, J Guzman, D Theegarten, K W Schmid, U Costabel.   

Abstract

Bronchoalveolar lavage (BAL) has become an established method for the diagnosis of infectious and interstitial lung diseases. Using a bronchoscope material from the peripheral airways and alveolar spaces can be obtained. When standard protocols are followed the procedure is generally well tolerated and in combination with clinical tests allows a reliable diagnosis in many cases. Certain clinical entities, e.g. alveolar proteinosis and Langerhans cell histiocytosis can be diagnosed by BAL alone without resorting to invasive diagnostic tests. In other diseases, BAL allows to narrow the range of the differential diagnosis. However, biopsies can often still not be avoided completely. A combination of both methods together with the clinical findings represents a powerful tool for diagnosis and research into the pathologic alterations in inflammatory and fibroising lung diseases.

Entities:  

Mesh:

Year:  2007        PMID: 17661044     DOI: 10.1007/s00292-007-0926-6

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  31 in total

Review 1.  Role of bronchoalveolar lavage in interstitial lung disease.

Authors:  R P Baughman; M Drent
Journal:  Clin Chest Med       Date:  2001-06       Impact factor: 2.878

2.  IMMUNOGLOBULINS IN NORMAL HUMAN TRACHEOBRONCHIAL WASHINGS: A QUALITATIVE AND QUANTITATIVE STUDY.

Authors:  R I KEIMOWITZ
Journal:  J Lab Clin Med       Date:  1964-01

Review 3.  Bronchoalveolar lavage in drug-induced lung disease.

Authors:  Ulrich Costabel; Esra Uzaslan; Josune Guzman
Journal:  Clin Chest Med       Date:  2004-03       Impact factor: 2.878

Review 4.  Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group.

Authors: 
Journal:  Eur Respir J       Date:  1989-06       Impact factor: 16.671

5.  Value of bronchoalveolar lavage in the management of severe acute pneumonia and interstitial pneumonitis in the immunocompromised child.

Authors:  J de Blic; P McKelvie; M Le Bourgeois; S Blanche; M R Benoist; P Scheinmann
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

Review 6.  Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1990-05

7.  Activation of neutrophils, eosinophils, and lymphocytes in the lower respiratory tract in Wegener's granulomatosis.

Authors:  A Schnabel; E Csernok; J Braun; W L Gross
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

8.  Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis.

Authors:  R H Winterbauer; J Lammert; M Selland; R Wu; D Corley; S C Springmeyer
Journal:  Chest       Date:  1993-08       Impact factor: 9.410

Review 9.  The alveolitis of hypersensitivity pneumonitis.

Authors:  U Costabel
Journal:  Eur Respir J       Date:  1988-01       Impact factor: 16.671

10.  Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage.

Authors:  U Costabel; H Teschler; J Guzman
Journal:  Eur Respir J       Date:  1992-07       Impact factor: 16.671

View more
  1 in total

1.  Bronchoscopic performance of bronchoalveolar lavage in germany - a call for standardization.

Authors:  Juergen Hetzel; Michael Kreuter; Christian M Kähler; Hans-Joachim Kabitz; Andreas Gschwendtner; Ralf Eberhardt; Ulrich Costabel; Kaid Darwiche
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-03-31       Impact factor: 0.670

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.